Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

SVP, Chief Development Officer

EVP & Chief Medical Officer

Chief Commercial Officer

EVP & Chief Scientific Officer

See Remarks

President and CEO

Chief Scientific Officer

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mec...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-22	Premium	acquired	Premium	Premium	Premium	-
2024-02-16	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-02-16	Premium	sold	Premium	Premium	Premium	SVP, Chief Development Officer
2024-02-16	Premium	sold	Premium	Premium	Premium	EVP & Chief Medical Officer
2024-02-16	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	EVP & Chief Medical Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	SVP, Chief Development Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	EVP & Chief Scientific Officer
2024-02-07	Premium	acquired	Premium	Premium	Premium	-
2024-01-16	Premium	sold	Premium	Premium	Premium	EVP & Chief Medical Officer
2024-01-16	Premium	sold	Premium	Premium	Premium	SVP, Chief Development Officer
2024-01-16	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-01-16	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-12-13	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-12-13	Premium	sold	Premium	Premium	Premium	See Remarks
2023-12-13	Premium	sold	Premium	Premium	Premium	EVP & Chief Medical Officer
2023-12-13	Premium	sold	Premium	Premium	Premium	President and CEO
2023-12-13	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-12-12	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2023-12-12	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-12-12	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-12-12	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-12-12	Premium	acquired	Premium	Premium	Premium	EVP & Chief Medical Officer

DCPH - Deciphera Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for DCPH